February 28, 2026 · The FREED Team
Nicotine pouches — ZYN, Velo, On!, and dozens of others — are the fastest-growing nicotine product on the market. They are marketed as tobacco-free, discreet, and a "cleaner" way to get nicotine.
But are they actually safe? And are they just as addictive?
The short answer: they are almost certainly less harmful than cigarettes. But "less harmful" and "safe" are not the same thing, and the distinction matters enormously if you are trying to make an informed decision about your health.
Nicotine pouches are small, white pouches containing synthetic nicotine (or tobacco-derived nicotine), flavourings, sweeteners, and a pH adjuster — typically sodium carbonate, which makes the nicotine more bioavailable by increasing the alkalinity. You place them between your lip and gum, and nicotine is absorbed through the oral mucosa directly into your bloodstream.
They contain no tobacco leaf, which is how they are marketed as "tobacco-free." This distinction is important for regulatory purposes, but it can also be misleading. The product does not contain tobacco, but it does contain nicotine — the same addictive chemical found in tobacco — and in many cases at very high concentrations.
Nicotine pouches typically come in strengths ranging from 2mg to 12mg or higher. For comparison, a single cigarette delivers roughly 1–2mg of absorbed nicotine. A high-strength pouch can deliver substantially more nicotine per use than a cigarette, and because pouches are used continuously — one after another, all day — total daily nicotine intake can be significant.
The growth of nicotine pouches has been staggering. In the United States, sales of nicotine pouches grew by over 300% between 2019 and 2022, according to data from the Centers for Disease Control and Prevention. ZYN, the dominant brand owned by Philip Morris International, sold over 385 million cans in the US in 2023 alone.
The demographics are shifting too. While nicotine pouches were initially adopted primarily by adult smokers looking for alternatives, they have become increasingly popular among younger adults and, concerning to public health officials, among teenagers. The flavoured varieties — mint, coffee, citrus — and the discreet form factor make them appealing to people who would never have considered smoking a cigarette.
Social media has amplified this trend. Nicotine pouch content has billions of views across platforms, and the products have been normalised in a way that traditional tobacco never was among younger demographics. This is not a niche product anymore. It is a mass-market nicotine delivery system.
Almost certainly, yes. Combustible cigarettes produce thousands of toxic chemicals through the burning process — tar, carbon monoxide, formaldehyde, benzene, arsenic, and dozens of known carcinogens. The smoke itself contains over 7,000 chemicals, at least 70 of which are known to cause cancer. Nicotine pouches do not involve combustion, so they avoid the vast majority of these.
There is no tar, no carbon monoxide, no particulate matter entering your lungs. For someone who would otherwise be smoking cigarettes, switching to nicotine pouches almost certainly reduces their exposure to the most dangerous components of tobacco use.
However, "safer than cigarettes" is an extremely low bar. Cigarettes kill roughly half of their long-term users. Almost anything is safer than inhaling burning tobacco. The more important question is whether nicotine pouches are safe in absolute terms.
This is a different question — and the honest answer is: we do not know yet.
Nicotine pouches in their current form have only been widely available since approximately 2016–2018. Long-term studies on their health effects do not exist because the products have not been around long enough to study long-term outcomes. Anyone who tells you they are definitively safe is making a claim that the science cannot support.
What we do know:
Nicotine itself is not harmless. Nicotine raises blood pressure, increases heart rate, and constricts blood vessels. It has been linked to cardiovascular issues independent of tobacco. Research published in the *European Heart Journal* has shown that nicotine can contribute to arterial stiffness and endothelial dysfunction — conditions that increase the risk of heart attack and stroke. Nicotine also affects insulin sensitivity, which has implications for metabolic health and diabetes risk.
Oral health concerns are real. Constant contact between the pouch and gum tissue creates direct chemical exposure at the application site. Users commonly report gum irritation, soreness, and localised inflammation. Studies on Swedish snus — a similar (though not identical) product that has been used for decades — have found associations with gum recession and changes in oral mucosal tissue. A 2021 review published in *Tobacco Control* noted that while the oral health risks of nicotine pouches appear lower than those of smokeless tobacco products containing tobacco leaf, the long-term effects on gum tissue, tooth enamel, and oral mucosa remain uncertain. Some dentists have reported seeing increased gum recession and white lesions at the pouch placement site in regular users.
The chemical additives warrant scrutiny. Nicotine pouches contain flavourings, sweeteners, pH adjusters, and stabilisers. While these ingredients are generally recognised as safe for ingestion, their safety profile when held against mucosal tissue for extended periods is less well studied. The pH adjusters in particular — which create an alkaline environment to improve nicotine absorption — may contribute to tissue irritation with repeated, prolonged use.
Effects on the developing brain. For adolescents and young adults whose brains are still developing (until approximately age 25), nicotine exposure carries additional risks. Nicotine can alter brain development, affect attention and learning, and prime the brain for addiction to other substances. The American Academy of Pediatrics has raised specific concerns about the growing use of nicotine pouches among young people.
The regulatory landscape for nicotine pouches is complex and evolving. In the United States, the FDA regulates nicotine pouches as tobacco products, even those containing synthetic nicotine, following the passage of legislation in 2022 that brought synthetic nicotine products under FDA authority.
As of early 2026, no nicotine pouch has received a Modified Risk Tobacco Product (MRTP) authorisation from the FDA. This means that no manufacturer has been granted permission to market their pouches as less harmful than other tobacco products. Philip Morris International submitted an MRTP application for ZYN, but a determination has not been finalised.
Some nicotine pouch products have received marketing authorisation through the Premarket Tobacco Product Application (PMTA) pathway, which means the FDA has determined that marketing those products is "appropriate for the protection of public health." This is not a safety endorsement — it is a regulatory determination that weighs the risks to individuals against the potential population-level benefits (such as smokers switching to a less harmful product).
In the European Union, nicotine pouches are regulated differently across member states, with some countries banning them outright and others allowing sales with varying restrictions. The lack of regulatory consistency reflects the scientific uncertainty surrounding these products.
This is the part that matters most. Nicotine pouches deliver nicotine efficiently and consistently. Many brands offer concentrations of 6mg or higher — enough to maintain a strong dependence. The nicotine in a pouch reaches your bloodstream within minutes and produces the same dopamine response in your brain's reward centre as nicotine from any other source.
The addiction is identical because the molecule is identical. Whether nicotine comes from a cigarette, a vape, or a pouch, it binds to the same nicotinic acetylcholine receptors, triggers the same dopamine release, and creates the same neurological dependence. Your brain does not care about the delivery method. It cares about the nicotine.
People who switch from cigarettes to pouches often believe they have solved their nicotine problem. They have not. They have changed the delivery method while maintaining the addiction. In many cases, the addiction actually intensifies.
And the discreet nature of pouches means people often use them more frequently than they smoked — in meetings, in bed, at the gym, on aeroplanes, in class. There is no need to step outside, no smoke smell to manage, no social stigma to navigate. This convenience removes the natural barriers that limited cigarette consumption. Total daily nicotine intake can actually increase substantially after switching to pouches, and with it, the depth of the addiction.
The withdrawal process is the same as quitting any nicotine product. Your brain has become dependent on regular nicotine input, and removing that input triggers a predictable set of withdrawal symptoms:
The approach is identical to quitting any nicotine product: stop completely, survive the 72-hour peak, use breathing exercises and accountability to get through cravings, and track your recovery.
One challenge specific to pouch users is the frequency of the habit. If you were using 15–20 pouches per day, you have 15–20 daily trigger moments to manage. Each time you would normally reach for a pouch — after a meal, during a meeting, while driving — you need a strategy. Planning for these moments in advance makes a significant difference.
Nicotine pouches are likely less harmful than cigarettes. For someone who would otherwise continue smoking, they may represent a harm reduction option — though this has not been formally established by regulatory authorities.
But they are not a solution to nicotine addiction — they are a continuation of it in a different form. They maintain the same chemical dependence, often increase total nicotine consumption, and their long-term health effects remain unknown.
If your goal is to be free from nicotine entirely — to not be dependent on any substance, to not organise your day around your next dose, to not spend money on a product that controls you — a pouch is not the answer. Quitting is.
The withdrawal is the same regardless of whether you are quitting cigarettes, vapes, or pouches. It lasts a few weeks. It is uncomfortable but temporary. And on the other side of it is freedom from all of it.
Are nicotine pouches better than vaping?
In terms of harm, the comparison is complex. Nicotine pouches avoid the risks associated with inhaling aerosolised chemicals into your lungs, which is a potential advantage over vaping. However, they involve direct and prolonged chemical contact with oral tissue, which carries its own risks. Both products deliver nicotine and are equally addictive. Neither is "safe" — they represent different risk profiles rather than a clear ranking. The safest option remains quitting nicotine entirely.
Can nicotine pouches cause mouth cancer?
There is currently no definitive evidence that nicotine pouches cause oral cancer. However, the products have not been available long enough for long-term cancer studies to be completed. Research on Swedish snus — a related product — has generally not found a strong association with oral cancer, but snus and nicotine pouches are not identical products. Some researchers have raised concerns about chronic mucosal irritation at the application site as a potential risk factor. The honest answer is that we will not know the full cancer risk profile for years or decades.
Is it harder to quit nicotine pouches than cigarettes?
The nicotine withdrawal experience is fundamentally the same regardless of the source. However, many pouch users report that the habit component is challenging because pouches are used so frequently and in so many different contexts. A cigarette smoker might smoke 15 times a day in specific locations; a pouch user might use 20+ pouches throughout the day in every setting. This means more trigger associations to break. The chemical withdrawal, however, follows the same timeline and resolves in the same way.
Should I switch to nicotine pouches to help me quit smoking?
Some harm reduction advocates suggest that switching to nicotine pouches can be a step toward quitting. The evidence for this is mixed. While it may reduce exposure to combustion-related toxins, many people who switch to pouches find themselves maintaining or increasing their nicotine dependence rather than tapering off. If your goal is to quit nicotine entirely, switching to a different nicotine product often just delays the quit. You will still need to go through withdrawal eventually — the question is whether you want to do it now or later.
1. Centers for Disease Control and Prevention. (2023). Smokeless Tobacco: Products and Marketing. https://www.cdc.gov/tobacco/about/smokeless-tobacco-products.html
2. U.S. Food and Drug Administration. (2024). Tobacco Product Marketing Orders. https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/tobacco-product-marketing-orders
3. Azzopardi, D., Liu, C., & Murphy, J. J. (2021). Chemical characterisation of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continua. *Drug and Chemical Toxicology*, 45(5), 2246–2254. https://pubmed.ncbi.nlm.nih.gov/34348557/
4. Benowitz, N. L. (2010). Nicotine addiction. *The New England Journal of Medicine*, 362(24), 2295–2303. https://pubmed.ncbi.nlm.nih.gov/20554984/
5. World Health Organization. (2023). Tobacco Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/tobacco